• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺相关病毒介导的survivin 突变 C84A 过表达抑制体内胃癌细胞生长。

Inhibition of gastric cancer cell growth in vivo by overexpression of adeno-associated virus-mediated survivin mutant C84A.

机构信息

Department of Thoracic and Cardiovascular Surgery, No. 4 People's Hospital of Wuxi City, Wuxi City, PR China.

出版信息

Oncol Res. 2013;20(9):411-7. doi: 10.3727/096504013X13657689383094.

DOI:10.3727/096504013X13657689383094
PMID:23924925
Abstract

Survivin is overexpressed in most of human cancer cells and tissues. Its overexpression is associated with apoptosis inhibition, drug resistance, and poor prognosis. In this study, we investigated the effect of adeno-associated virus (AAV)-mediated survivin mutant Cys84Ala [rAAV-Sur-Mut(C84A)] on gastric cancer growth. Sur-Mut(C84A) was subcloned into the AAV expression vector pAM/CAG to generate recombinant (r)AAV-Sur-Mut(C84A) virus. Cell survival was determined by the MTT method. Apoptosis was measured by FACS analysis and TUNEL. Tumor growth was assessed using a xenograft mouse model. Results showed that treatment of rAAV-Sur-Mut(C84A) virus significantly reduced cell survival, induced apoptosis, and sensitized gastric cancer cells to 5-fluorouracil in vitro. Furthermore, treatment of rAAV-Sur-Mut(C84A) virus markedly induced apoptosis and inhibited gastric cancer growth in vivo. Moreover, rAAV-Sur-Mut(C84A) treatment strongly enhanced the antitumor activity of 5-fluorouracil. Our results suggest that the combination of rAAV-Sur-Mut(C84A) with chemotherapy may be a promising strategy for gastric cancer therapy.

摘要

Survivin 在大多数人类癌细胞和组织中过度表达。其过度表达与细胞凋亡抑制、耐药和预后不良有关。在这项研究中,我们研究了腺相关病毒 (AAV) 介导的 survivin 突变型 Cys84Ala [rAAV-Sur-Mut(C84A)] 对胃癌生长的影响。Sur-Mut(C84A) 被亚克隆到 AAV 表达载体 pAM/CAG 中,以生成重组 (r)AAV-Sur-Mut(C84A) 病毒。通过 MTT 法测定细胞存活率。通过 FACS 分析和 TUNEL 测定凋亡。使用异种移植小鼠模型评估肿瘤生长。结果表明,rAAV-Sur-Mut(C84A) 病毒处理显著降低细胞存活率,诱导细胞凋亡,并增强胃癌细胞对体外 5-氟尿嘧啶的敏感性。此外,rAAV-Sur-Mut(C84A) 病毒处理显著诱导体内细胞凋亡并抑制胃癌生长。此外,rAAV-Sur-Mut(C84A) 处理强烈增强了 5-氟尿嘧啶的抗肿瘤活性。我们的结果表明,rAAV-Sur-Mut(C84A) 与化疗的联合可能是胃癌治疗的一种有前途的策略。

相似文献

1
Inhibition of gastric cancer cell growth in vivo by overexpression of adeno-associated virus-mediated survivin mutant C84A.腺相关病毒介导的survivin 突变 C84A 过表达抑制体内胃癌细胞生长。
Oncol Res. 2013;20(9):411-7. doi: 10.3727/096504013X13657689383094.
2
Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant.腺相关病毒载体介导的生存素Cys84Ala突变体转移用于结肠癌的基因治疗
Gastroenterology. 2005 Feb;128(2):361-75. doi: 10.1053/j.gastro.2004.11.058.
3
Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer.腺相关病毒介导的survivin 突变体 Thr34Ala 与奥沙利铂协同抑制结肠癌的肿瘤生长和血管生成。
Oncol Rep. 2011 Apr;25(4):1039-46. doi: 10.3892/or.2011.1166. Epub 2011 Jan 28.
4
Overexpression of Survivin mutant Thr34Ala induces apoptosis and inhibits gastric cancer growth.生存素突变体Thr34Ala的过表达诱导细胞凋亡并抑制胃癌生长。
Neoplasma. 2015;62(1):81-7. doi: 10.4149/neo_2015_010.
5
Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.重组腺相关病毒2介导的抗血管生成预防在腹腔内卵巢癌小鼠模型中的应用
Clin Cancer Res. 2005 Feb 1;11(3):1342-7.
6
Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.通过 hTERT 启动子驱动的腺相关病毒载体介导 IFN-β表达抑制小鼠肿瘤生长。
Cancer Lett. 2009 Dec 28;286(2):196-205. doi: 10.1016/j.canlet.2009.05.024. Epub 2009 Jun 28.
7
Potent antitumour activity of the combination of HSV-TK and endostatin armed oncolytic adeno-associated virus for bladder cancer in vitro and in vivo.携带 HSV-TK 和内皮抑素的溶瘤腺相关病毒联合应用在膀胱癌的体内外研究中显示出强大的抗肿瘤活性。
J Surg Oncol. 2012 Mar;105(3):249-57. doi: 10.1002/jso.22107. Epub 2011 Sep 27.
8
Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.hTERT 启动子驱动的表达凋亡素的溶瘤腺病毒治疗胃癌的疗效。
Int J Mol Med. 2012 Oct;30(4):747-54. doi: 10.3892/ijmm.2012.1077. Epub 2012 Jul 25.
9
Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.肿瘤靶向腺相关病毒载体介导的干扰素β与TRAIL联合应用对A549肺癌异种移植瘤的抗肿瘤作用增强
Sheng Wu Gong Cheng Xue Bao. 2010 Jun;26(6):780-8.
10
Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.慢病毒介导的 VEGF 靶向 siRNA 抑制体内胃癌生长。
Oncol Rep. 2012 Nov;28(5):1687-92. doi: 10.3892/or.2012.1966. Epub 2012 Aug 10.

引用本文的文献

1
Adeno-associated virus (AAV) vectors in cancer gene therapy.癌症基因治疗中的腺相关病毒(AAV)载体。
J Control Release. 2016 Oct 28;240:287-301. doi: 10.1016/j.jconrel.2016.01.001. Epub 2016 Jan 12.
2
Targeting carbonic anhydrase IX activity and expression.靶向碳酸酐酶IX的活性和表达。
Molecules. 2015 Jan 30;20(2):2323-48. doi: 10.3390/molecules20022323.